name: Intra-arterial injection of tissue plasminogen activator


name: Incisional biopsy of seminiferous tubule for spermatozoa extraction using operating microscope


name: Ultrasonography guided aspiration of seminal fluid from seminal vesicle


name: Diagnostic loop electrosurgical excision procedure


name: TWEAK (Tolerance, Worry, Eye-opener, Amnesia, K/Cut down) questionnaire


name: Implantation of osseointegrated implant into bone of jaw


name: Endoscopic debridement of pancreatic and peripancreatic necrosis


name: Endoscopic argon plasma coagulation of pancreas


name: Ability to manage residence-related activities


name: Preparation of core of tooth using Nayyar technique with composite dental filling material


name: Fluoroscopy guided replacement of intrathecal implantable infusion pump and intrathecal catheter


name: Fluoroscopy guided replacement of pump segment of intrathecal catheter


name: Fluoroscopy guided replacement of spinal segment of microspinal catheter


name: Ankle and/or foot component of lower limb orthosis


name: Mechanical resistance knee component of lower limb orthosis


name: Electromechanical or electrohydraulic knee component of lower limb orthosis


name: Custom made intestinal ostomy base plate


name: Preparation of core of tooth using Nayyar technique with amalgam dental filling material


name: Restoration of tooth using ceramic overlay


name: Gait rehabilitation electronic wheeled walker


name: Reinforcement of education on use of wheeled walker


name: Reinforcement of education on use of walking frame


name: Fluoroscopy guided local anesthetic and corticosteroid atlantoaxial joint nerve block


name: Esophagogastroduodenoscopy and closure of duodenal fistula


name: Restoration of tooth using metal overlay


name: Percutaneous endoscopic creation of jejunostomy


name: Restoration of tooth using metal dental crown


name: Restoration of tooth with full cuspal coverage using dental filling material


name: Imaging guided percutaneous irreversible electroporation ablation of neoplasm of liver


name: Do not attempt cardiopulmonary resuscitation order


name: Coordination of care of subject with caregiver


name: Education about document translation service


name: Education about language interpretation service


name: Excision of malignant neoplasm of skin of upper limb


name: Excision of malignant neoplasm of skin of lower limb


name: Laparoscopic irreversible electroporation ablation of neoplasm of liver


name: Open irreversible electroporation of neoplasm of liver


name: Caregiver referred to diabetes structured education program


name: Fluoroscopy guided replacement of intrathecal implantable infusion pump and spinal segment of intrathecal catheter


name: Injection of botulinum toxin type A into detrusor muscle of urinary bladder


name: Reduction of intussusception of intestine using enema


name: Accident while engaged in military training


name: Evaluation of eligibility for financial assistance program


name: Education about telephone support program


name: Education about financial assistance program


name: Choledochoscopic electrohydraulic lithotripsy of calculus of biliary tract


name: Percutaneous injection of ethanol into neoplasm of liver


name: Accident while engaged in hunting activity


name: Accident while engaged in school activity


name: Education about workforce transition program


name: Evaluation of eligibility for workforce transition program


name: Percutaneous coronary intervention on mid-segment of left main coronary artery


name: Percutaneous coronary intervention on distal segment of left main coronary artery


name: Fluoroscopy guided local anesthetic and corticosteroid atlantooccipital joint nerve block


name: Implantation of permanent spinal cord stimulator


name: Evaluation of eligibility for adult learning center


name: Referral to Mindfulness Based Stress Reduction program


name: Education about Mindfulness Based Stress Reduction program


name: Mindfulness Based Stress Reduction program


name: Revision of total prosthetic replacement of wrist joint


name: Heated and humidified high flow oxygen therapy using nasal cannula


name: Fixation of fracture of bone of spine using bone screw internal spinal fixation system


name: Open reduction of fracture of bone of spine and internal fixation using bone screw internal spinal fixation system


name: Reconstruction of anterior skull base using pedicle inferior turbinate flap


name: Insertion of dental bridge with resin and base metal pontic onto tooth


name: Revision of open reduction of fracture of bone of spine and internal fixation using bone screw internal spinal fixation system


name: Intensity of stain of estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry


name: Intensity of stain of progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry


name: Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of breast by immunohistochemistry


name: Percent of cells with estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry


name: Percent of cells with progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry


name: Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of breast by immunohistochemistry


name: Application of glass-ionomer dental material to dentin of tooth following fracture of tooth


name: Application of composite dental filling material to dentin of tooth following fracture of tooth


name: Restoration of tooth using prefabricated zirconia dental crown


name: Education about prevention of dental trauma


name: Irrigation of ventricular intracranial catheter


name: Endovascular repair of aortic aneurysm using endovascular stent graft and stent graft anchoring system


name: Endovascular repair of thoracic aortic aneurysm using endovascular stent graft and stent graft anchoring system


name: Reconstruction of breast using subglandular prosthesis


name: Replacement of subpectoral space prosthetic breast implant with prepectoral space prosthetic breast implant


name: Replacement of prepectoral space prosthetic breast implant with subpectoral space prosthetic breast implant


name: Strand displacement amplification technique


name: Enzyme-linked fluorescence assay technique


name: Elevation of gingival flap and open debridement of surface of oral implant


name: Insertion of membrane and fixation pin into periodontal tissue


name: Assistance with application for microenterprise development program


name: Evaluation of eligibility for microenterprise development program


name: Administration of substance via nasojejunal route


name: Anchoring of aortic endovascular stent graft to vessel wall using endovascular stent graft anchoring system


name: Anchoring of thoracic aortic endovascular stent graft to vessel wall using endovascular stent graft anchoring system


name: External drainage of brain ventricle using twist drill hole technique


name: Education about microenterprise development program


name: Referral to microenterprise development program


name: Removal of supragingival plaque and calculus from all teeth using dental instrument


name: Removal of subgingival plaque and calculus from all teeth using dental instrument


name: Debridement of pressure injury stage II of sacral region


name: Debridement of pressure injury stage III of sacral region


name: Debridement of pressure injury stage IV of sacral region


name: Excision of pressure injury stage II of ischial region with excision of ischium and primary closure using suture


name: Excision of pressure injury stage III of ischial region with excision of ischium and primary closure using suture


name: Excision of pressure injury stage IV of ischial region with excision of ischium and primary closure using suture


name: Reconstruction of pressure injury stage II


name: Reconstruction of pressure injury stage III


name: Reconstruction of pressure injury stage IV


name: Insertion of autologous fascial pubovaginal sling


name: EDQM pharmaceutical dose forms to SNOMED CT simple map with correlation reference set


name: Insertion of autologous fascial midurethral sling


name: Repair of multiple tears of rotator cuff of right shoulder


name: Repair of multiple tears of rotator cuff of left shoulder


name: Open reconstruction of acetabular labrum


name: Arthroscopic reconstruction of acetabular labrum


name: Arthroscopic repair of acetabular labrum


name: Arthroscopic debridement of acetabular labrum


name: Endoscopic removal of bulking agent from outlet of male urinary bladder


name: Endoscopic removal of bulking agent from outlet of female urinary bladder


name: Endoscopic wide local excision of breast lesion


name: Delayed reconstruction of breast with local muscle flap


name: Immediate reconstruction of breast with local muscle flap


name: Immediate reconstruction of breast with free flap


name: Delayed reconstruction of breast with free flap


name: Breast reconstruction with submuscular implant


name: Stereotactic mammography guided insertion of marker into breast


name: Status of estrogen receptor stain in control cells by immunohistochemistry


name: Status of progesterone receptor stain in control cells by immunohistochemistry


name: ALUMINUM CHLOROHYDRATE ANHYDROUS 0.22 g in 1 g TOPICAL STICK [Every Man Jack Cedarwood Antiperspirant]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 130 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL LOTION [Walgreens SPF 50 Sport Faces]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 130 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [CVS Health Sport SPF 50 Face]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 130 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [Walgreens SPF 50 Sport Faces]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen Broad Spectrum SPF 50 Plus Primer and Moisturizer with Antioxidant Vitamin E]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [TOO FACED HANGOVER GOOD TO GO SPF 25 BROAD SPECTRUM MOISTURIZER]


name: OCTINOXATE 67 mg in 1 mL / TITANIUM DIOXIDE 115 mg in 1 mL TOPICAL LIQUID [Lancome Paris Teint Idole Ultra Wear Breathable Coverage Foundation Reno Broad Spectrum SPF 25 Sunscreen]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 35 mg in 1 mL / TITANIUM DIOXIDE 17 mg in 1 mL TOPICAL CREAM [REPAIRWEAR UPLIFTING FIRMING BROAD SPECTRUM SPF 15 DRY]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 44 mg in 1 mL / TITANIUM DIOXIDE 35 mg in 1 mL / ZINC OXIDE 22 mg in 1 mL TOPICAL CREAM [AGE DEFENSE BB BROAD SPECTRUM SPF 30 ALL SKIN TYPES]


name: OCTINOXATE 75 mg in 1 mL / TITANIUM DIOXIDE 29 mg in 1 mL TOPICAL LIQUID [TOM FORD SOLEIL GLOW TINTED MOISTURIZER BROAD SPECTRUM SPF 15]


name: TITANIUM DIOXIDE 65 mg in 1 mL / ZINC OXIDE 25 mg in 1 mL TOPICAL CREAM [REDNESS solutions DAILY PROTECTIVE BASE BROAD SPECTRUM SPF 15]


name: TITANIUM DIOXIDE 73 mg in 1 mL / ZINC OXIDE 69 mg in 1 mL TOPICAL CREAM [CITY BLOCK SHEER Oil FREE DAILY FACE PROTECTOR BROAD SPECTRUM SPF 25]


name: ZINC OXIDE 22.75 g in 100 g TOPICAL LIPSTICK [SPF50 SHEER GLOW BALM TRIO]


name: DEXTROMETHORPHAN HYDROBROMIDE 10 mg in 5 mL / GUAIFENESIN 100 mg in 5 mL / PHENYLEPHRINE HYDROCHLORIDE 5 mg in 5 mL NOT APPLICABLE SYRUP [Dimacol]


name: OCTINOXATE 20 mg in 1 g / AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OXYBENZONE 60 mg in 1 g TOPICAL AEROSOL, SPRAY [CVS Health SPF 100 Clear]


name: OCTINOXATE 59 mg in 1 mL / TITANIUM DIOXIDE 37 mg in 1 mL / ZINC OXIDE 29 mg in 1 mL TOPICAL LOTION [REDNESS solutions MAKEUP BROAD SPECTRUM SPF 15 WITH PROBIOTIC TECHNOLOGY]


name: OCTINOXATE 60 mg in 1 mL / TITANIUM DIOXIDE 38 mg in 1 mL / ZINC OXIDE 30 mg in 1 mL TOPICAL LOTION [EVEN BETTER GLOW LIGHT REFLECTING MAKEUP BROAD SPECTRUM SPF 15]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 45 mg in 1 mL / TITANIUM DIOXIDE 46 mg in 1 mL / ZINC OXIDE 50 mg in 1 mL TOPICAL CREAM [Clinique Broad Spectrum SPF 30 Oil Free Face With Solar Smart]


name: OCTISALATE 50 mg in 1 mL / AVOBENZONE 20 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTOCRYLENE 15 mg in 1 mL TOPICAL LOTION [CVS Health SPF 50]


name: TITANIUM DIOXIDE 63 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL LOTION [PEP-STAR DAILY UV PROTECTOR BROAD SPECTRUM SPF 50]


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [Big Lots Soundbody SPF 30 Ultra Sport Sunscreen]


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [CVS Health SPORT SPF 30]


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [Equaline SPORT Sunscreen SPF 30]


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [Market Basket Moisturizing Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [TopCare Everyday SPORT Sun Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 27 mg in 1 mL / OXYBENZONE 50 mg in 1 mL TOPICAL CREAM [CLINIQUE BROAD SPECTRUM SPF 50 SUNSCREEN BODY WITH SOLAR SMART]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL CREAM [CLINIQUE FOR MEN SUPER ENGERGIZER ANTI -FATIGUE HYDRATING Concentrate BROAD SPECTRUM SPF 25]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL CREAM [CLINIQUE SMART CUSTOM REPAIR MOISTURIZER BROAD SPECTRUM SPF 15 - VERY DRY/DRY]


name: HOMOSALATE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Big Lots Soundbody SPF 50 Ultra Sport Sunscreen]


name: HOMOSALATE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [CVS Health Sport SPF 50]


name: HOMOSALATE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Equaline Sport Sunscreen SPF 50]


name: HOMOSALATE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Market Basket Moisturizing Sunscreen Broad Spectrum SPF 50]


name: HOMOSALATE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [TopCare Everyday Sport Sun SPF 50]


name: ZINC OXIDE 0.16 g in 1 g TOPICAL LOTION [Aquation Anti-Chafe Cream]


name: Northside Hospital H.E.A.R.T. Strings KIT


name: AVOBENZONE 20 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL AEROSOL, SPRAY [CVS Health Sport SPF 15 Clear]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 23.5 mg in 1 g TOPICAL AEROSOL, SPRAY [HARMON FACE VALUES REFRESHING COOLING BODY MIST SUNSCREEN SPF 45]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 130 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios Kids Gentle Broad Spectrum SPF 50 Sunscreen for Face and Body Water Resistant 80 Minutes]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Kiehls Since 1851 Dermatologist Solutions Super Fluid Daily UV Defense Broad Spectrum SPF 50 plus Sunscreen Antipollution Lightweight Formula]


name: AVOBENZONE 30 mg in 1 mL / OXYBENZONE 50 mg in 1 mL / OCTINOXATE 74.9 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Paulas Choice RESIST Skin Restoring Moisturizer SPF 50]


name: Avobenzone 30 mg in 1 mL / Homosalate 100 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 70 mg in 1 mL TOPICAL LIQUID [Maybelline New York Fit Me Matte Plus Poreless Mattifying Poreless Primer Broad Spectrum SPF 20 Sunscreen]


name: TITANIUM DIOXIDE 9.95 g in 100 mL / ZINC OXIDE 7 g in 100 mL TOPICAL CREAM [PURLISSE AGELESS GLOW BB SPF 40]


name: ZINC OXIDE 9.3 g in 100 g / HOMOSALATE 10 g in 100 g TOPICAL CREAM [Prevention Daily Matte Moisturizer SPF 30]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 8 g in 100 mL / OCTISALATE 4 g in 100 mL / OCTOCRYLENE 2 g in 100 mL TOPICAL LOTION [SAND AND SKY TINTED GLOW PRIMER SPF30]


name: AVOBENZONE 3 g in 100 mL / OCTISALATE 4.7 g in 100 mL / OCTOCRYLENE 8.4 g in 100 mL TOPICAL LOTION [Nivea Men Maximum Hydration Face]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [Big Lots Soundbody SPF 50 Ultra Shield Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [CVS Health SPF 30 Ultra Protection]


name: AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / HOMOSALATE 100 mg in 1 mL TOPICAL OIL [The Better Oil]


name: ZINC OXIDE 15.52 g in 50 mL TOPICAL CREAM [ISA KNOX ANEW SOLAIRE EVERYDAY MINERAL FACE PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN]


name: ZINC OXIDE 150 mg in 1 mL TOPICAL LOTION [Sqween 100% Mineral Sunscreen Broad Spectrum SPF 30 Water Resistant]


name: ZINC OXIDE 17.8 g in 100 mL TOPICAL LOTION [Fieldtrip - Whatever the Weather Daily Moisturizer Zinc Oxide Sunscreen - SPF 30]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 60 mg in 1 mL TOPICAL LOTION [My day screen Tinted drops Mini 30 SPF Light Medium]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 90 mg in 1 mL TOPICAL LOTION [Fair Light Tinted Drops]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 90 mg in 1 mL TOPICAL LOTION [My day screen Tinted drops Mini 30 SPF Fair Light]


name: OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Hydrating Body Sunscreen]


name: TITANIUM DIOXIDE 0.747 mg in 1 mL TOPICAL LIQUID [bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen DEEPEST DEEP 30]


name: TITANIUM DIOXIDE 3.9 g in 100 mL / ZINC OXIDE 3.2 g in 100 mL TOPICAL LOTION [Jack Black Dual Defense Face Moisturizer - SPF 30]


name: TITANIUM DIOXIDE 65 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL LOTION [Tinted Body Screen Medium Bronze]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL AEROSOL, SPRAY [WALGREENS SPF 100 SHEER BODY SUNSCREEN MIST]


name: TITANIUM DIOXIDE 35 mg in 1 g / ZINC OXIDE 72.5 mg in 1 g TOPICAL SPRAY [TopCare Everyday Mineral Sunscreen Continuous Broad Spectrum SPF 50 Reef-Conscious Formula]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL AEROSOL, SPRAY [CVS HEALTH SPORT SPF 50 CLEAR SUNSCREEN]


name: lancet with blood glucose test strips and pen needles MISCELL COMBINATION PACKAGE (EA)


name: blood glucose meter/insulin data transf accessory, bluetooth MISCELL KIT


name: data transfer accessory (insulin pen), bluetooth MISCELL EACH


name: electrolytes/dextr/vit C/vit D3/turmeric rt xt/elderberry fr 270 mg-25 mcg-140 mg-50 mg ORAL POWDER IN PACKET (EA)


name: electrolytes/dextrose/ascorbic acid/elderberry fruit 1,000 mg-300 mg ORAL EFFERVESCENT POWDER IN PACKET


name: gauze bandage 4.5" X 2.5 yard TOPICAL BANDAGE


name: infant formula with iron/docosahexaenoic acid/arachidonic ac 2.1 gram-5.3 gram-11.3 gram/100 kcal ORAL LIQUID (ML)


name: Ensure Max Protein Nutrition Shake Chocolate


name: First Response Early Result Pregnancy Test


name: First Response Rapid Result Pregnancy Test


name: Just For Men Control GX Grey-Reducing Shampoo


name: Just For Men Dark Brown Facial Haircolor Kit


name: TensCare I Sock For Foot Pain And Arthritis


name: Tenscare Electrodes Butterfly Pads 105x155 mm


name: Tenscare I Glove For Hand Pain And Arthritis


name: Tenscare I Glove, M For Hand Pain, Arthritis


name: Tenscare I Sock M For Foot Pain And Arthritis


name: TensCare iTouch Sure Pelvic Floor Exerciser


name: TensCare Kegel Toner Pelvic Floor Trainer


name: Tenscare Kneestim For Knee Pain And Arthritis


name: TensCare Pain Aide Drug Free Pain Relief


name: Trojan Arouses And Intensifies Lubricants


name: Trojan Bareskin Get Closer Latex Condoms


name: Trojan Bareskin Thinnest Textured Condoms


name: Trojan ENZ Spermicidal Lubricant Condoms


name: Trojan H2O Closer Water-Based Lubricants


name: Trojan Magnum Bareskin Large Size Condoms


name: Trojan Magnum Large Size Lubricated Condoms


name: Trojan Magnum Lubricated Latex Condoms XL


name: Trojan Magnum Ribbed Lubricated Condoms L


name: Trojan Pleasure Pack Lubricated Latex Condoms


name: Trojan Ultra Ribbed Ecstasy Lubricated Condom


name: Trojan Ultra Thin Lubricant Latex Condoms


name: Williams Lectric Shave Green Tea Complex


name: Xymogen SAM-e And TMG Lemon Flavor Stick Pack


name: Just For Men Real Black Easy Comb-In Color


name: Just For Men Real Black Shampoo-In Haircolor


name: Just For Men Medium Brown Brush-In Color Gel


name: Just For Men Medium Brown Shampoo-In Color


name: TV Heargear Awareness Mode Wireless Earphones


name: Centor Amber Oval Prescription Bottle 1OZ


name: data transfer accessory (insulin pen), bluetooth


name: AVOBENZONE 2 mg in 100 mL / OCTOCRYLENE 2 mg in 100 mL / OCTISALATE 4 mg in 100 mL / HOMOSALATE 4 mg in 100 mL TOPICAL LOTION [ROC MULTI CORREXION EVEN TONE LIFT DAILY MOISTURIZER SPF30]


name: HOMOSALATE 10 g in 100 mL / OCTOCRYLENE 8 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL LOTION


name: HOMOSALATE 10 g in 100 mL / OCTOCRYLENE 8 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL LOTION [Sand Sky Australian Sunshield Body Sunscreen SPF50 plus]


name: Homosalate 50 mg in 1 mL / Zinc oxide 30 mg in 1 mL TOPICAL LOTION [All Day Moisture]


name: TITANIUM DIOXIDE 1.52 g in 100 g / ZINC OXIDE 9.7 g in 100 g / OCTINOXATE 7 g in 100 g / OCTISALATE 3 g in 100 g / BEMOTRIZINOL 2.5 g in 100 g TOPICAL CREAM [ELROEL Pang Pang Big Sun Cushion S7]


name: TITANIUM DIOXIDE 100 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL LOTION [Vivier Sheer SPF 30 Mineral Tinted]


name: TITANIUM DIOXIDE 4 g in 100 g / ZINC OXIDE 19.5 g in 100 g TOPICAL AEROSOL [Hawaiian Blend Essential Zinc SPF 30]


name: TITANIUM DIOXIDE 4 g in 100 g / ZINC OXIDE 19.5 g in 100 g TOPICAL AEROSOL [Hawaiian Blend Extreme Zinc SPF 50]


name: ZINC OXIDE 80 mg in 1 mL / TITANIUM DIOXIDE 100 mg in 1 mL TOPICAL LOTION [Vivier Sheer SPF 30 Mineral]


name: ZINC OXIDE 99 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Vivier Sheer SPF 45]


name: ALLANTOIN 10 mg in 1 mL TOPICAL GEL [Macoma Senior Premium Cleanser]


name: magnesium carbonate, citrate, oxide, gluconate


name: FEEDING BAG W/PUMP SET INFINITY #INF0500-E


name: TUBE FEEDING SET,EXTENSION BOLUS AMT #6-1211


name: DRESSING,FOAM SILICONE 4IN X 4IN KENDALL #FM44


name: TRACH TUBE,SZ 10 CUFFED SMITH #101815100


name: VALVE,ENFIT,LOPEZ ENTERAL,ICU MEDICAL #9000-SEF


name: CATHERIZATION SET,FOLEY 18FR BARD #899918


name: CATHETER,SELF-CATH PLUS 12FR COLOPLAST #4812


name: BrainSustain For Kids Powder for Suspension (Vanilla Delight)


name: CVS Mepilex Border Foam Adhesive Dressing


name: Enfagrow NEURO PRO Toddler Nutritional Drink (Natural Milk)


name: Enfamil Gentlease with Iron Powder for Suspension


name: Enterade IBS-D Oral Solution (Mixed Berry)


name: FRESH Every Time 5 Day 25% Antiperspirant & Deodorant Pads


name: Nutricia Pepticate with Iron Infant Formula


name: TensCare Electrodes 25mm Electrical Patch


name: TensCare Electrodes 50x100mm Electrical Patch


name: TensCare Electrodes 50x50mm Electrical Patch


name: TensCare Electrodes 50x90mm Electrical Patch


name: TensCare Electrodes Butterfly 105x155mm Electrical Patch


name: TensCare Electrodes Face 30x50mm Electrical Patch


name: TensCare Electrodes Joint 150mm Electrical Patch


name: TensCare KegelFit Pelvic Floor Muscle Stimulator


name: TensCare Nouri Duo Automatic Breast Pump


name: TensCare Perfect EMS Electrotherapy Device


name: TensCare Sports TENS 2 Electrotherapy Device


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 30 mg in 1 mL / OCTOCRYLENE 27 mg in 1 mL TOPICAL CREAM [VITAZING SPF 15 ENERGY BOOSTING MOISTURIZER WITH MANGOSTEEN BROAD SPECTRUM SPF 15]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Men]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Sem perfume]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Sport Men]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Sport Unissex]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Sport Women]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Teen Boy]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Teen Girl]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Unissex]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Women]


name: ZINC OXIDE 15.6 g in 100 g TOPICAL CREAM [Prevention Sun Serum SPF 30 Tinted]


name: {4 (lenacapavir 300 MG Oral Tablet) } Pack


name: {4 (lenacapavir 300 MG Oral Tablet [Sunlenca]) } Pack [Sunlenca 4-Tablet Pack]


name: {5 (lenacapavir 300 MG Oral Tablet) } Pack


name: {5 (lenacapavir 300 MG Oral Tablet [Sunlenca]) } Pack [Sunlenca 5-Tablet Pack]


name: {2 (1.5 ML lenacapavir 309 MG/ML Injection) } Pack


name: {2 (1.5 ML lenacapavir 309 MG/ML Injection [Sunlenca]) } Pack [Sunlenca 927 MG Kit]


name: AVOBENZONE 2.5 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL CREAM [Prevention Clear Solar Gel SPF30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 10 mg in 1 mL TOPICAL SPRAY [Sunscreen]


name: ZINC OXIDE 12 g in 100 mL TOPICAL LOTION [DAILY SPF PRIMER SPF 50]


name: ZINC OXIDE 15.6 g in 100 g TOPICAL CREAM [Prevention Sun Serum SPF30]


name: AVOBENZONE 20 mg in 1 mL / OCTOCRYLENE 20 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Austalian Gold Broad Spectrum SPF 15 Sunscreen]


name: AVOBENZONE 29.19 mg in 1 mL / OCTISALATE 48.65 mg in 1 mL / OCTOCRYLENE 48.65 mg in 1 mL / HOMOSALATE 72.98 mg in 1 mL TOPICAL LOTION [Australian Gold Instant Bronzer 30 sunscreen]


name: Solution, Multi Ingredient Topical application Pad [NEUTROGENA MAKEUP REMOVER]


name: Lotion, Multi Ingredient Topical application Lotion [AVEENO SHEER HYDRATION LOTION]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-10%-5%-10% Topical application Spray [NEUTROGENA ULTRA SHEER SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-15%-5%-10% Topical application Lotion [BEACH DEFENSE 70 SUNSCREEN]


name: Titanium Dioxide/Zinc Oxide 5%-3% Topical application Lotion


name: Titanium Dioxide/Zinc Oxide 5%-3% Topical application Lotion [NEUTROGENA HEALTHY DEFENSE]


name: Avobenzone/Octocrylene/Oxybenzone 3%-10%-6% Topical application Cream [MEDERMA SCAR CREAM + SPF 30]


name: Formula, Infant Oral Powder for Suspension [PEPTICATE]


name: Formula, Infant Oral Powder for Suspension [BABY'S OWN ORGANIC DHA & ARA TODDLER]


name: Medical Food Oral Solution [ENTERADE IBS-D]


name: Cleanser Topical application Lotion [GENTLE SKIN CLEANSER]


name: SENNOSIDES 15 kg in 15 kg POWDER [Calcium Sennosides 60%]


name: AVOBENZONE 29.55 mg in 1 mL / HOMOSALATE 98.5 mg in 1 mL / OCTISALATE 49.25 mg in 1 mL / OCTOCRYLENE 49.25 mg in 1 mL TOPICAL LOTION [Australian Gold Broad Spectrum SPF 50]


name: {1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) } Pack


name: {1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension) } Pack


name: {2 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) } Pack


name: {1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) / 1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension) } Pack


name: {2 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension) } Pack


name: {1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension) / 1 (sodium phenylbutyrate 3670 MG Granules for Oral Suspension) } Pack


name: HOMOSALATE 40.05 mg in 1 mL / OCTISALATE 44.5 mg in 1 mL / AVOBENZONE 26.7 mg in 1 mL / OCTOCRYLENE 80.1 mg in 1 mL TOPICAL GEL [Black Girl Sunscreen Sungloss for Lips]


name: OCTINOXATE 50 mg in 1 mL / TITANIUM DIOXIDE 31 mg in 1 mL / ZINC OXIDE 22 mg in 1 mL TOPICAL EMULSION [BORN THIS WAY HEALTHY GLOW SPF30]


name: TITANIUM DIOXIDE 63 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL LOTION [CLINIQUE SPF 50 BROAD SPECTRUM MINERAL SUNSCREEN FLUID FOR FACE]


name: ZINC OXIDE 15 g in 100 mL / OCTINOXATE 7.5 g in 100 mL TOPICAL LOTION [Cyberderm Every Morning Sun Whip]


name: {1 (dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 13.33 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution) / 1 (diphenhydramine hydrochloride 0.833 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution) } Pack


name: Titanium Dioxide 80 mg in 1 g / Zinc Oxide 38 mg in 1 g TOPICAL CREAM [Emme Diane Tinted Mineral Sunscreen]


name: OXIBENDAZOLE 1 kg in 1 kg NOT APPLICABLE POWDER [OXIBENDAZOLE]


name: RONIDAZOLE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ALUMINUM CHLOROHYDRATE 20 g in 100 g TOPICAL AEROSOL, SPRAY


name: AVOBENZONE 2.5 g in 100 g / OCTISALATE 2.15 g in 100 g / HOMOSALATE 3.5 g in 100 g / OCTOCRYLENE 5.0 g in 100 g TOPICAL STICK [Refreshing Water Hydration Stick SPF 50]


name: ZINC OXIDE 13.63 g in 100 g TOPICAL STICK [Mineral Sunscreen Stick SPF 50 Fragrance-Free]


name: ZINC OXIDE 17.9 g in 100 g TOPICAL STICK [Bare Republic Mineral SPF 50]


name: OCTOCRYLENE 9.5 g in 100 mL / AVOBENZONE 2.8 g in 100 mL / HOMOSALATE 9.8 g in 100 mL / OCTISALATE 4.9 g in 100 mL TOPICAL LOTION [Vacation SPF 50 Classic]


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Emzahh 28 Day]


name: HOMOSALATE 8.8 g in 100 mL / AVOBENZONE 2.9 g in 100 mL / OCTOCRYLENE 8.6 g in 100 mL / OCTISALATE 4.9 g in 100 mL TOPICAL SPRAY [Vacation SPF 50 Classic]


name: Leucine 0.0025 g in 5 mL / Isoleucine 0.0025 g in 5 mL TOPICAL LIQUID [ExoSCRT Derma Signal SRLV Vial 2. Diluent]


name: ZINC OXIDE 17 g in 100 g TOPICAL LOTION [LESS EVERY TONE SPF 30]


name: ZINC OXIDE 94 mg in 1 mL TOPICAL CREAM [Curology Everyday Sunscreen Broad Spectrum SPF 30 No-clog UV defense]


name: HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / ZINC OXIDE 70 mg in 1 mL TOPICAL CREAM [Face Cream 50]


name: Zinc Oxide 10.5 g in 100 g TOPICAL STICK [Norwex Natural Sunscreen Lip Balm Broad Spectrum SPF 15]


name: Zinc Oxide 20 g in 100 g TOPICAL OINTMENT [Norwex Natural Sunscreen Broad Spectrum SPF 30]


name: Aluminum Sesquichlorohydrate 0.15 kg in 1 kg TOPICAL Lotion [Carpe Antiperspirant Underarm Coconut Vanilla Scent]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Smooth Even Glow Tinted Mineral Sunscreen Broad Spectrum SPF30]


name: ZINC OXIDE 0.21 g in 1 g / TITANIUM DIOXIDE 0.06 g in 1 g TOPICAL POWDER [Brush on Block Mineral Powder Sunscreen Translucent]


name: ZINC OXIDE 20.5 g in 100 g TOPICAL LOTION [TRADER JOES ZINC OXIDE SUNSCREEN SPF 40]


name: GUANABENZ ACETATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 14 g in 100 mL TOPICAL LOTION [Rose Inc. Solar Power Luminous Serum SPF30]


name: TITANIUM DIOXIDE 5.76 g in 100 g / ZINC OXIDE 2.94 g in 100 g TOPICAL CREAM [Super CC Color Correction Care Cream]


name: diphenhydramine / hydrocortisone / pramoxine


name: HOMOSALATE 9.8 mg in 100 mL / OCTISALATE 4.9 mg in 100 mL / AVOBENZONE 2.9 mg in 100 mL / OCTOCRYLENE 9.5 mg in 100 mL TOPICAL SPRAY [Glow Baby Brightening Setting Mist SPF 45]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Antioxidant Tinted Mineral Sunscreen Broad Spectrum SPF30]


name: ZINC OXIDE 10 g in 100 g TOPICAL STICK [Attitude Oceanly Phyto-Sun Tinted - SPF 15 - Broad Spectrum Sunscreen]


name: ZINC OXIDE 14.5 g in 100 mL TOPICAL LIQUID [Sun Plus Skincare SPF 30 Mineral Bronzing Sunscreen Coconut Glow]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OXYBENZONE 60 mg in 1 g TOPICAL SPRAY [CVS Health Sport SPF 70 Clear]


name: ISOFLUPREDONE ACETATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: Idoxuridine 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 16 g in 100 mg TOPICAL CREAM [Sun Plus Skincare SPF 30 Mineral Face Shade Coconut Probiotic]


name: ATIPAMEZOLE HYDROCHLORIDE 1 kg in 1 kg NOT APPLICABLE POWDER


name: Skin substitute, fda cleared as a device, not otherwise specified


name: Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service


name: Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service


name: Cranial electrotherapy stimulation (ces) system supplies and accessories, per month


name: Prescription digital cognitive and/or behavioral therapy, fda cleared, per course of treatment


name: Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable)


name: Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system


name: Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controller


name: Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed, first 20 sq cm or less with manual preparation and insertion of deep (eg, subfacial) drug-delivery device(s)


name: Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)


name: Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)


name: Open biopsy or excision of deep cervical node(s) with intraoperative identification (eg, mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed


name: Percutaneous vertebroplasties (bone biopsies included when performed), first cervicothoracic and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance


name: Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance


name: Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (eg, kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance


name: Percutaneous vertebral augmentations, first lumbar and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (eg, kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance


name: Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed


name: Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with computer-assisted image-guided navigation, including fluoroscopic guidance when performed


name: Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed


name: Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance when performed


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with all angioplasty in the central dialysis segment, and transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with dialysis circuit permanent endovascular embolization or occlusion of main circuit or any accessory veins, including all required imaging, radiological supervision and interpretation, image documentation and report


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) includes intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty and all angioplasty in the central dialysis segment, with transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging, radiological supervision and interpretation, documentation and report


name: Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy


name: Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal stent placement(s), includes angioplasty within the same vessel, when performed, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable debribrillator or pacemake pulse generator (eg, for upgrade to dual chamber system)


name: Insertion of new or replacement of permanent pacemaker with ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defribrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)


name: Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)


name: Removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator, dual lead system, with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)


name: Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Percutaneous exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), with removal of calculi/debris from biliary duct(s) and/or gallbladder, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, including diagnostic cholangiography(ies) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation


name: Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation


name: Convert nephrostomy catheter to nephroureteral catheter, percutaneous via pre-existing nephrostomy tract, with ureteral stricture balloon dialation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation


name: Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation


name: Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation


name: Cystourethroscopy, with biopsy(ies) with adjuctive blue light cystoscopy with fluorescent imaging agent


name: Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress, initial vessel


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed


name: Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent imaging agent


name: Thyroidectomy, total or complete with parathyroid autotransplantation


name: Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, initial 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service


name: Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, initial 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service


name: Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)


name: Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed


name: Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study


name: Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catherization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study


name: Adjunctive, non-implanted continuous glucose monitor or receiver


name: Non-adjunctive, non-implanted continuous glucose monitor or receiver


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 5 to 15 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 16-30 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 16-30 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 16-30 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)


name: Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)


name: Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes)


name: Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418). (do not report g0317 for any time unit less than 15 minutes)


name: Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99345, 99350 for home or residence evaluation and management services). (do not report g0318 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99417). (do not report g0318 for any time unit less than 15 minutes)


name: Home health services furnished using synchronous telemedicine rendered via a real-time two-way audio and video telecommunications system


name: Home health services furnished using synchronous telemedicine rendered via telephone or other real-time interactive audio-only telecommunications system


name: The collection of physiologic data digitally stored and/or transmitted by the patient to the home health agency (i.e., remote patient monitoring)


name: Care management services for behavioral health conditions, at least 20 minutes of clinical psychologist, clinical social worker, mental health counselor, or marriage and family therapist time, per calendar month. (these services include the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, coordination with and/or referral to physicians and practitioners who are authorized by medicare to prescribe medications and furnish e/m services, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team)


name: Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room


name: Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.)


name: Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.)


name: Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis


name: Skills training and development, per diem


name: Cranial electrotherapy stimulation (ces) system, any type


name: Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist


name: Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application


name: Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply


name: External recharging system for battery (internal) for use with implanted cardiac contractility modulation generator, replacement only


name: Non-pneumatic compression controller without calibrated gradient pressure


name: Non-pneumatic sequential compression garment, full leg


name: Non-pneumatic sequential compression garment, half leg


name: Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count


name: Advancing cancer care mips value pathways


name: Optimal care for kidney health mips value pathways


name: Optimal care for patients with episodic neurological conditions mips value pathways


name: Supportive care for neurodegenerative conditions mips value pathways


name: Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring


name: Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency


name: Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency


name: Human health factor 10 amniotic patch (hhf10-p), per square centimeter


name: Celera dual layer or celera dual membrane, per square centimeter


name: Dual layer impax membrane, per square centimeter


name: Counseling, individual, by chaplain services


name: Services performed by a doula birth worker, per 15 minutes


name: Services performed by a doula birth worker, per diem


name: Financial management, self-directed, waiver; per diem


name: Supports brokerage, self-directed, waiver; per diem


name: Contact lens, hydrophilic, dual focus, per lens


name: Audiology service furnished personally by an audiologist without a physician/npp order for non-acute hearing assessment unrelated to disequilibrium, or hearing aids, or examinations for the purpose of prescribing, fitting, or changing hearing aids; service may be performed once every 12 months, per beneficiary


name: Temporary Codes Assigned to DME Regional Carriers - Self-administered test


name: Oncology (oropharyngeal), evaluation of 17 DNA biomarkers using droplet digital PCR (ddPCR), cell-free DNA, algorithm reported as a prognostic risk score for cancer recurrence


name: Neurology (mild cognitive impairment), analysis of β-amyloid 1-42 and 1-40, chemiluminescence enzyme immunoassay, cerebral spinal fluid, reported as positive, likely positive, or negative


name: Oncology (prostate cancer), analysis of all prostate-specific antigen (PSA) structural isoforms by phase separation and immunoassay, plasma, algorithm reports risk of cancer


name: Oncology (lung), enzyme-linked immunosorbent assay (ELISA) of 7 autoantibodies (p53, NY-ESO-1, CAGE, GBU4-5, SOX2, MAGE A4, and HuD), plasma, algorithm reported as a categorical result for risk of malignancy


name: Neurofilament light chain, digital immunoassay, plasma, quantitative


name: Oncology (papillary thyroid cancer), gene-expression profiling via targeted hybrid capture-enrichment RNA sequencing of 82 content genes and 10 housekeeping genes, fine needle aspirate or formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as one of three molecular subtypes


name: Oncology (urothelial), mRNA, gene-expression profiling by real-time quantitative PCR of 5 genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm incorporates age, sex, smoking history, and macrohematuria frequency, reported as a risk score for having urothelial carcinoma


name: Medical Dictionary for Regulatory Activities Terminology (MedDRA), Arabic Edition


name: Biloxi-Chitimacha Confederation of Muskogee


name: Edisto Natchez Kusso Tribe of South Carolina


name: Pribilof Islands Aleut Communities of St. Paul and St. George Islands


name: San Manuel Band of Mission Indians, California


name: Te-Moak Tribe of Western Shoshone Indians of Nevada


name: abacavir, lamivudine, and zidovudine drug combination


name: Diversity, Equity, Inclusion, and Belonging


name: Diversity, Equality, Inclusion, and Accessibility


name: Death Valley Timbisha Shoshone Band of California


name: Arapaho Tribe of the Wind River Reservation, Wyoming


name: Native Village of Venetie Tribal Government


name: Burt Lake Band of Ottawa and Chippewa Indians


name: Lumbee TribeLumbee Tribe of North Carolina


name: Ma-Chis Lower Creek Indian Tribe of Alabama


name: Mackinac Bands of Chippewa and Ottawa Indians


name: Bayou Lafourche Band of Biloxi-Chitimacha Confederation of Muskogees


name: Nulhegan Band of the Coosuk Abenaki Nation


name: Paucatuck Eastern Pequot Indians of Connecticut


name: Pee Dee Indian Nation of Upper South Carolina


name: Piscataway Indian Nation and Tayac Territory


name: Swan Creek Black River Confederated Ojibwa Tribes of Michigan


name: Ute Mountain Tribe of the Ute Mountain Reservation, Colorado, New Mexico and Utah


name: Prenatal visits for this pregnancy:Find:Pt:^Patient:Ord


name: Cardiac device monitoring report:Find:Pt:Heart:Doc


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Discharge Goal:-:RptPeriod:^Patient:-:CMS Assessment


name: Health informatics leader and champion of semantic interoperability


name: Health informatics leader and champion of semantic interoperability:Hx:Pt:^Patient:Nar


name: Semen & urine analysis fertility panel:-:Pt:XXX:-


name: Portable medical order completion information


name: Portable medical order completion information:-:-:^Patient:-:POLST


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Admission Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Health informatics pioneer and cofounder of LOINC


name: Health informatics pioneer and cofounder of LOINC:Hx:Pt:^Patient:Nar


name: Change in mental status:Find:Pt:^Patient:Ord


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Admission Performance


name: CD49d cell expression evaluation:Find:Pt:XXX:Doc:Flow cytometry


name: CD20 cell expression evaluation:Find:Pt:XXX:Doc:Flow cytometry


name: Organ &or tissue donation consent:Find:Pt:{Setting}:Doc:Patient


name: Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]


name: Aryl Hydrocarbon Receptor Agonists [MoA]


name: destruction of nasal turbinate (treatment)


name: occlusion of inferior vena cava (treatment)


name: occlusion of superior vena cava (treatment)


name: MDS v3.0 - RAI v1.18.11 - Mobility - Discharge Goal


name: Chief technical architect and steadfast leader of LOINC


name: Chief technical architect and steadfast leader of LOINC:Hx:Pt:^Patient:Nar


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Discharge Goal


name: Health informatics pioneer and the father of LOINC


name: Health informatics pioneer and the father of LOINC:Hx:Pt:^Patient:Nar


name: CHAMPS pediatric fall risk assessment:-:Pt:^Patient:-:CHAMPS


name: Schmid fall risk assessment:-:Pt:^Patient:-:Schmid


name: MMP1, 1-BP INS, -1607G, PROMOTER (dbSNP rs1799750)


name: DGAT1, 3-BP DEL, 629CCT (dbSNP rs782577883)


name: OBSCN, IVS24DS, G-T, +1 (dbSNP rs200849058)


name: HSD17B13, IVS6DS, 1-BP INS, A (dbSNP rs72613567)


name: TANGO2, 34-KB DEL, EX3-9DEL (dbSNP SCV000245443)


name: International Classification for Nursing Practice, 2022


name: Pathology report.additional specified observation:Find:Pt:Specimen:Nar


name: Pathology report.additional specified observation


name: Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel:-:Pt:Nose:-:Non-probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Nose:Ord:Non-probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Nose:Ord:Non-probe.amp.tar


name: JC virus Ab Index:ACnc:Pt:Ser/Plas:Qn:IA


name: Varicella Zoster Virus DNA:LnCnc:Pt:XXX:Qn:Probe.amp.tar


name: HIV reverse transcriptase failed codons:Prid:Pt:Isolate:Nom:Genotyping


name: HIV 1 group M RNA genotype:Prid:Pt:Isolate:Nom:Genotyping


name: HIV protease failed codons:Prid:Pt:Isolate:Nom:Genotyping


name: HIV integrase failed codons:Prid:Pt:Isolate:Nom:Genotyping


name: Lymphocyte T-cell & B-cell & Natural killer subsets panel:-:Pt:CSF:-


name: Blood group antigens panel:-:Pt:RBC^Father:-


name: CD52 cell expression evaluation:Find:Pt:XXX:Doc:Flow cytometry


name: B-cell CD19 & CD20 subsets panel:-:Pt:Bld:-:Flow cytometry


name: Respiratory Allergen Panel, Area 5:-:Pt:Ser:-


name: Cortisol post dose insulin IV panel:-:Pt:Ser/Plas:-


name: Somatotropin post dose insulin IV panel:-:Pt:Ser/Plas:-


name: Monkeypox virus sequencing panel:-:Pt:XXX:-:Sequencing


name: Discharge summary note:Find:Pt:{Setting}:Doc:Osteopathic medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Medical aid in dying


name: History and physical note:Find:Pt:{Setting}:Doc:Integrative medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Bariatric surgery


name: History and physical note:Find:Pt:{Setting}:Doc:Chiropody


name: History and physical note:Find:Pt:{Setting}:Doc:Chiropractic medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Community health care


name: History and physical note:Find:Pt:{Setting}:Doc:Clinical cardiac electrophysiology


name: History and physical note:Find:Pt:{Setting}:Doc:Surgical oncology


name: History and physical note:Find:Pt:{Setting}:Doc:Undersea and hyperbaric medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Kinesiotherapy


name: History and physical note:Find:Pt:{Setting}:Doc:Hospitalist


name: History and physical note:Find:Pt:{Setting}:Doc:Nuclear medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Diabetology


name: History and physical note:Find:Pt:{Setting}:Doc:Optometry


name: History and physical note:Find:Pt:{Setting}:Doc:Osteopathic medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Orthotics prosthetics


name: History and physical note:Find:Pt:{Setting}:Doc:Reproductive endocrinology and infertility


name: History and physical note:Find:Pt:{Setting}:Doc:Sports medicine


name: History and physical note:Find:Pt:Urgent care center:Doc:{Role}


name: History and physical note:Find:Pt:{Setting}:Doc:Child and adolescent psychology


name: History and physical note:Find:Pt:{Setting}:Doc:Cardiac surgery


name: History and physical note:Find:Pt:{Setting}:Doc:Hematology+Medical oncology


name: History and physical note:Find:Pt:{Setting}:Doc:Neuropsychology


name: Progress note:Find:Pt:Urgent care center:Doc:{Role}


name: Consultation note:Find:Pt:Urgent care center:Doc:{Role}


name: Consultation note:Find:Pt:{Setting}:Doc:Undersea and hyperbaric medicine


name: Surgical operation note:Find:Pt:{Setting}:Doc:Bariatric surgery


name: Surgical operation note:Find:Pt:{Setting}:Doc:Reproductive endocrinology and infertility


name: Conference note:Find:Pt:{Setting}:Doc:Critical care medicine.team


name: Conference note:Find:Pt:{Setting}:Doc:Rapid response team


name: A little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: B little e super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: C little r super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: C little s super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: C little s super little b Ag:PrThr:Pt:RBC:Ord


name: D little h super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: D little r super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: E little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: E little s super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: H little r super little s Ab:PrThr:Pt:Ser/Plas:Ord


name: H little r super B Ab:PrThr:Pt:Ser/Plas:Ord


name: H little u little t Ab:PrThr:Pt:Ser/Plas:Ord


name: I little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: J little o super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11:-:RptPeriod:^Patient:-:CMS Assessment


name: Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11


name: MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set


name: National Council of State Boards of Nursing ID:ID:Pt:Provider:Nom


name: National Council of State Boards of Nursing ID


name: Thrombospondin type I domain-containing 7A Ag:PrThr:Pt:Tiss:Ord:IF


name: Sezary syndrome monitoring:Find:Pt:Bld:Doc:Flow cytometry


name: Sezary syndrome diagnosis:Find:Pt:Bld:Doc:Flow cytometry


name: Leukemia and lymphoma immunophenotyping:Find:Pt:XXX:Doc:Flow cytometry


name: Bacterial carbapenem resistance blaIMI gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaIMI+blaNMC genes:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaOXA-235-like gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaOXA-24+blaOXA-40 genes:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaSIM gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Theoretical limit of detection:Num:Pt:XXX:Qn:Calculated


name: Mast cells/100 cells:NFr:Pt:Bone mar:Qn:Flow cytometry


name: B-cell precursors:NFr:Pt:Bone marrow:Qn:Flow cytometry


name: Glucose post XXX challenge panel:-:Pt:Ser/Plas:-


name: End of treatment letter:Find:Pt:{Setting}:Doc:Radiation oncology


name: ER super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: NAT2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: NAT2 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen


name: NAT2 gene product metabolic activity interpretation


name: Ustekinumab & Ustekinumab Ab panel:-:Pt:Ser/Plas:-


name: Ustekinumab & Ustekinumab Antibody panel


name: Monocyte subsets panel:-:Pt:Bld:-:Flow cytometry


name: Borrelia burgdorferi Ab.IgM index:ACnc:Pt:Ser+CSF:Qn


name: Mitochondria whole genome analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Chemokine (C-C motif) ligand 14:MCnc:Pt:Urine:Qn:IA


name: Soluble urokinase plasminogen activator receptor:MCnc:Pt:Ser/Plas:Qn


name: Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis rRNA panel:-:Pt:XXX:-:Probe.amp.tar


name: Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis rRNA panel


name: Pneumocystis jiroveci DNA:ThreshNum:Pt:Respiratory System Specimen:Qn:Probe.amp.tar


name: Sphincter excision plane:Anat:Pt:Colorectal cancer specimen:Nom


name: Mesocolic excision plane:Anat:Pt:Colorectal cancer specimen:Nom


name: Depth of invasion beyond muscularis propria:Len:Pt:Colorectal cancer specimen:Qn


name: Depth of invasion beyond muscularis propria


name: Inflammatory cell infiltrate:Find:Pt:Colorectal cancer specimen:Nom


name: Lymph nodes with metastasis/Lymph nodes examined:NFr:Pt:Colorectal cancer specimen:Qn


name: Lymph nodes with metastasis/Lymph nodes examined


name: Measles virus Ab.IgG index:ACnc:Pt:Ser+CSF:Qn


name: Mumps virus Ab.IgG index:ACnc:Pt:Ser+CSF:Qn


name: Herpes simplex virus 1+2 Ab.IgG index:ACnc:Pt:Ser+CSF:Qn


name: Varicella zoster virus Ab.IgA:ACnc:Pt:Ser/Plas:Qn:IA


name: Dengue virus NS1 Ag:ACnc:Pt:Ser/Plas:Qn:IA


name: Hepatitis E virus Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hepatitis E virus Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus Ab.IgG panel:-:Pt:Ser/Plas:-:Line blot


name: Hantavirus puumala Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus sin nombre Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus hantaan Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus Ab.IgM panel:-:Pt:Ser/Plas:-:Line blot


name: Hantavirus puumala Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus sin nombre Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus hantaan Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus dobrava Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: SUMO-activating enzyme subunit 1 Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: PM-SCL-100 extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA


name: PKD1 gene & PKD2 gene deletion+duplication:Find:Pt:Bld/Tiss:Doc:MLPA


name: Hemosiderin:PrThr:Pt:Bld/Bone mar:Ord:Prussian blue stain


name: Purkinje cell cytoplasmic type Tr Ab:PrThr:Pt:CSF:Ord:IB


name: Zinc finger protein of the cerebellum 4 Ab:PrThr:Pt:Ser:Ord:IB


name: Zinc finger protein of the cerebellum 4 Ab:PrThr:Pt:CSF:Ord:IB


name: Glutamate decarboxylase 65 Ab:PrThr:Pt:CSF:Ord:IB


name: Glutamate decarboxylase 65 Ab:PrThr:Pt:Ser:Ord:IB


name: Glial nuclear type 1 Ab:PrThr:Pt:CSF:Ord:IB


name: Glial nuclear type 1 Ab:PrThr:Pt:Ser:Ord:IB


name: Mean chromosome banding resolution:Num:Pt:Bld/Tiss:Qn:Banding


name: Contactin-associated protein 2 Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Contactin-associated protein 2 Ab:PrThr:Pt:CSF:Ord:IF


name: Dipeptidyl aminopeptidase-like protein 6 Ab:PrThr:Pt:CSF:Ord:IF


name: Dipeptidyl aminopeptidase-like protein 6 Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Leucine-rich glioma-inactivated protein 1 Ab:PrThr:Pt:CSF:Ord:IF


name: Leucine-rich glioma-inactivated protein 1 Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Dense fine speckled 70 protein Ab:PrThr:Pt:Ser/Plas:Ord


name: Herpes virus 6 DNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:ACnc:Pt:Bld:Qn:Probe.amp.tar


name: Silica clotting time.excess phospholipid actual/Normal:RelTime:Pt:PPP:Qn


name: Silica clotting time.excess phospholipid actual/Normal


name: MDS v3.0 - RAI v1.18.11 - Identification Information:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Identification Information


name: MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision


name: MDS v3.0 - RAI v1.18.11 - Cognitive Patterns:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Cognitive Patterns


name: MDS v3.0 - RAI v1.18.11 - Mood:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Behavior:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Admission:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA &or Interim:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA &or Interim


name: MDS v3.0 - RAI v1.18.11 - Bladder and Bowel:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Bladder and Bowel


name: MDS v3.0 - RAI v1.18.11 - Active Diagnoses:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Active Diagnoses


name: MDS v3.0 - RAI v1.18.11 - Health Conditions:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Health Conditions


name: MDS v3.0 - RAI v1.18.11 - Swallowing &or Nutritional Status:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Swallowing &or Nutritional Status


name: MDS v3.0 - RAI v1.18.11 - Oral &or Dental Status:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Oral &or Dental Status


name: MDS v3.0 - RAI v1.18.11 - Skin Conditions:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Skin Conditions


name: MDS v3.0 - RAI v1.18.11 - Medications:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Header - Special Treatments, Procedures, and Programs:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Header - Special Treatments, Procedures, and Programs


name: MDS v3.0 - RAI v1.18.11 - Restraints and Alarms:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Restraints and Alarms


name: MDS v3.0 - RAI v1.18.11 - Participation in Assessment and Goal Setting:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Participation in Assessment and Goal Setting


name: MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary


name: MDS v3.0 - RAI v1.18.11 - Correction Request:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Correction Request


name: MDS v3.0 - RAI v1.18.11 - Assessment Administration:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Assessment Administration


name: Pharyngeal pathogens DNA & RNA panel:-:Pt:Thrt:-:Non-probe.amp.tar


name: Human coronavirus 229E+HKU1+NL63+OC43 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: SARS coronavirus 2 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus A H1 2009 pandemic RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus A H3 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Parainfluenza virus 1+2+3+4 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Respiratory syncytial virus RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Streptococcus dysgalactiae subspecies equisimilis DNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Views 2 && Views AP + lateral:Find:Pt:Chest>Spine.thoracic && Abdomen:Doc:XR


name: Dengue virus 1+2+3+4 RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Glucose post arginine stimulation panel:-:Pt:Ser/Plas:-


name: Glucose^2H post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin post insulin stimulation panel:-:Pt:Ser/Plas:-


name: Somatotropin post insulin stimulation panel


name: 17-Hydroxyprogesterone^30M post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone post corticotropin stimulation panel:-:Pt:Ser/Plas:-


name: 17-Hydroxyprogesterone post corticotropin stimulation panel


name: 17-Hydroxypregnenolone & 17-Hydroxyprogesterone post corticotropin stimulation panel:-:Pt:Ser/Plas:-


name: 17-Hydroxypregnenolone & 17-Hydroxyprogesterone post corticotropin stimulation panel


name: Cortisol & 17-Hydroxyprogesterone post corticotropin stimulation panel:-:Pt:Ser/Plas:-


name: Cortisol & 17-Hydroxyprogesterone post corticotropin stimulation panel


name: 17-Hydroxypregnenolone^30M post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Cortisol & Cortisone panel:-:24H:Urine:-


name: MDS v3.0 - RAI v1.18.11 - Mobility - Admission Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Mobility - Admission Performance


name: MDS v3.0 - RAI v1.18.11 - Mobility - Discharge Goal:-:RptPeriod:^Patient:-:CMS Assessment


name: Tub &or shower transfer - functional goal:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Pain assessment interview:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Pain assessment interview


name: Nutritional approaches - on admission:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Nutritional approaches - at discharge:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Participation in assessment and goal setting:-:RptPeriod:^Patient:-:CMS Assessment


name: Number of venous and arterial ulcers:Num:RptPeriod:^Patient:Qn:CMS Assessment


name: Ulcers, wounds and skin problems:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Reason referral to local contact agency not made:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Determination of pressure injury risk:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: W little r super little b Ag:PrThr:Pt:RBC:Ord


name: Treatment preferences under certain health conditions:Find:Pt:^Patient:Nar:Reported


name: Coagulation factor X inhibitor:ACnc:Pt:PPP:Qn:Chromo


name: Erythrocytes.parasite sp infected/100 cells:NFr:Pt:Bld:Qn


name: Erythrocytes.parasite sp infected/100 cells


name: Acute febrile illness global pathogens panel:-:Pt:Bld:-:Non-probe.amp.tar


name: Acute febrile illness global pathogens panel


name: MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs


name: Return to Community:-:RptPeriod:^Patient:-:CMS Assessment


name: Palmitoyl protein thioesterase & Tripeptidyl peptidase I panel:-:Pt:Bld.dot:-


name: Palmitoyl protein thioesterase & Tripeptidyl peptidase I panel


name: Jurisdiction where advance directive is accepted:Loc:Pt:^Patient:Nom


name: Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Borrelia burgdorferi Ab.IgG & IgM with reflex to immunoassay panel:-:Pt:Ser/Plas:-


name: Borrelia burgdorferi Ab.IgG & IgM with reflex to immunoassay panel


name: Bacillus anthracis plasmid pXO1 DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Bacillus anthracis plasmid pXO2 DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Bacillus anthracis DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Bacillus anthracis plasmid pXO1 DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Bacillus anthracis plasmid pXO2 DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Yersinia pestis DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Referral has been made to the local contact agency:Find:-:Patient education material:Ord:CMS Assessment


name: Troponin I.cardiac^2H post baseline measurement:MCncDiff:Pt:Ser/Plas:Qn:Calculated


name: inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript:Find:Pt:Bld/Bone mar:Doc:Molgen


name: Lung cancer targeted gene fusion transcript analysis:Find:Pt:Tiss:Doc:Sequencing


name: Lung cancer targeted gene fusion transcript analysis


name: BAP1 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: BAP1 gene deletion+duplication & full mutation analysis


name: FH gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: FH gene deletion+duplication & full mutation analysis


name: NF1 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: NF1 gene deletion+duplication & full mutation analysis


name: RET gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: RET gene deletion+duplication & full mutation analysis


name: HBA1 & HBA2 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GP1BB gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GP1BA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GP9 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: PAH gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: ADA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CLCN7 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Copy number variation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Monkeypox virus & Orthopoxvirus.non-variola DNA panel:-:Pt:XXX:-


name: monkeypox virus and non-variola orthopoxvirus DNA panel


name: Monkeypox virus & Orthopoxvirus.non-variola DNA:Prid:Pt:XXX:Nom:Probe.amp.tar


name: Metanephrine, Normetanephrine, 3-Methoxytyramine panel:-:24H:Urine:-


name: Metanephrine, Normetanephrine, 3-Methoxytyramine panel


name: Tapentadol & Nortapentadol panel:-:Pt:Urine:-


name: Phenylalanine & Tyrosine panel:-:Pt:Ser/Plas:-


name: Borrelia afzelii+burgdorferi+garinii Ab.IgG & IgM panel:-:Pt:Ser/Plas:-:IA


name: Amyloid protein:Find:Pt:Tiss:Doc:Congo red stain+LC/MS/MS


name: Anaplasma phagocytophilum & Babesia microti & Ehrlichia chaffeensis Ab.IgG panel:-:Pt:Ser:-


name: C peptide post XXX challenge panel:-:Pt:Ser:-


name: Lymphocyte TCR alpha beta double negative subsets panel:-:Pt:Bld:-


name: Lymphocyte TCR alpha beta double negative subsets panel


name: Blastomyces sp & Blastomyces dermatitidis Ag panel:-:Pt:Urine:-


name: Blastomyces sp & Blastomyces dermatitidis Ag panel


name: Pediatric autoimmune central nervous system disorders evaluation panel:-:Pt:CSF:-


name: Pediatric autoimmune central nervous system disorders evaluation panel


name: Pediatric autoimmune central nervous system disorders evaluation panel:-:Pt:Ser/Plas:-


name: Microorganism level of similarity to reference sample:Score:Pt:Isolate/Specimen:Qn:MS.MALDI-TOF


name: Human coronavirus 229E RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Human coronavirus HKU1 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Human coronavirus NL63 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Human coronavirus OC43 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Influenza virus A H1 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Influenza virus A H3 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Respiratory syncytial virus A RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Respiratory syncytial virus B RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Varicella zoster virus DNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Self-Care - Discharge Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Self-Care - OBRA/Interim Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Mobility - Discharge Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Mobility - OBRA/Interim Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Intentional animal genomic alteration label:-:-:^FDA product label:Nar


name: Intentional animal genomic alteration label


name: CHAMPS pediatric fall risk assessment:Imp:Pt:^Patient:Ord:CHAMPS


name: Soluble urokinase plasminogen activator receptor:MCnc:Pt:Plas:Qn


name: Solitary lung nodule risk of malignancy:Scale:Pt:^Patient:Ord:Calculated.Nodify XL2


name: Solitary lung nodule risk of malignancy:Scale:Pt:^Patient:Ord:Calculated.Nodify CDT


name: Contactin-associated protein 1 Ab.IgG & Neurofascin155 Ab.IgG4 panel:-:Pt:Ser/Plas:-


name: Contactin-associated protein 1 Antibody.immunoglobulin G & Neurofascin155 Antibody.IgG4 panel


name: Contactin-associated protein 1 Ab.IgG:PrThr:Pt:Ser/Plas:Ord:CBA IFA


name: Risk adjustment coding gap report:Find:Pt:{Setting}:Doc:{Role}


name: HBA1+2 gene FIL deletion:PrThr:Pt:Bld:Ord:Molgen


name: HBA1+2 gene THAI deletion:PrThr:Pt:Bld:Ord:Molgen


name: Alpha globin gene deletion panel:-:Pt:Bld:-


name: Adenovirus DNA & Human Metapneumovirus & Rhinovirus RNA panel:-:Pt:Respiratory System Specimen:-:Probe.amp.tar


name: Adenovirus DNA & Human Metapneumovirus & Rhinovirus RNA panel


name: Bacterial susceptibility panel:-:Pt:Bld.pos growth:-:MIC.VOC detection


name: Colony count:NCnc:Pt:XXX:Qn:Culture.standard plate count


name: Salmonella enterica serotype 1,4,[5],12:i:-:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Equine herpesvirus 1 non-neuropathogenic A2254 variant DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Equine herpesvirus 1 neuropathogenic G2254 variant DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Canine parvovirus DNA VP2 gene:PrThr:Pt:Isolate:Ord:Sequencing


name: Canine Parvovirus 2 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Hemorrhagic enteritis virus Ab:Titr:Pt:Ser:SemiQn:IA


name: Hemorrhagic enteritis virus Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Hemorrhagic enteritis virus Ab/Positive control


name: Porcine deltacoronavirus S gene:Seq:Pt:Isolate:Nom:Sequencing


name: Bovine parainfluenza virus 3 Ab.Neut:Titr:Pt:Ser:SemiQn:Neut


name: Porcine epidemic diarrhea virus S1 gene:Prid:Pt:Isolate:Nom:Sequencing


name: Porcine epidemic diarrhea virus Ab.IgG:ACnc:Pt:XXX:Qn:IA


name: Porcine epidemic diarrhea virus S1 gene Ab.IgA:ACnc:Pt:Saliva:Qn:IA


name: Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to RespPRRS:NFr:Pt:Isolate:Qn:Sequencing


name: Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to RespPRRS


name: Fungal 18S rRNA gene:Prid:Pt:XXX:Nom:Sequencing


name: Fungal 18S rRNA gene:Seq:Pt:XXX:Nom:Sequencing


name: Salmonella sp whole genome:Seq:Pt:Isolate:Nom:Sequencing


name: Comprehensive plan of care note:Find:Pt:{Setting}:Doc:Multidisciplinary


name: Bacterial versus viral etiology indicator panel:-:Pt:Ser/Plas:-


name: Bacterial versus viral etiology indicator panel


name: Tumor necrosis factor ligand superfamily member 10:MCnc:Pt:Ser/Plas/Bld:Qn


name: Bacterial versus viral infection likelihood:Score:Pt:^Patient:Qn:Calculated


name: Bacterial versus viral infection likelihood


name: Hepatocyte Ag by paraffin 1:Find:Pt:Bld/Tiss:Ord:Immune stain


name: Schmid fall risk assessment:Imp:Pt:^Patient:Ord:Schmid


name: Escherichia coli enteroinvasive DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Sapovirus genogroups I+II+IV RNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Sapovirus genogroup V RNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Thyroglobulin & Thyroglobulin Ab panel:-:Pt:Tiss.FNA:-


name: Bacterial gyrB gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Multisection transthoracic limited for congenital disease:Find:Pt:Chest>Heart:Doc:US


name: Multisection transthoracic limited for congenital disease


name: Multisection transthoracic for congenital disease:Find:Pt:Chest>Heart:Doc:US


name: Multisection transthoracic for congenital disease


name: Views for protein-losing enteropathy^W Tc-99m HSA IV:Find:Pt:Abdomen+Pelvis>Gastrointestinal tract:Doc:NM


name: Borrelia burgdorferi Ab.IgG bands:Num:Pt:CSF:Qn:IB


name: Borrelia burgdorferi Ab.IgM bands:Num:Pt:CSF:Qn:IB


name: MDS v3.0 - RAI v1.17.1, 1.17.2 - Special treatments, procedures, and programs


name: MDS v3.0 - RAI v1.14.1 - Participation in assessment and goal setting


name: How much of the time has pain made it hard for you to sleep at night


name: How often have you limited your day-to-day activities because of pain


name: How often have you limited your participation in rehabilitation therapy sessions due to pain over